Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Urgent National Cancer Plan Needed for England's Crisis
Research & Development Urgent National Cancer Plan Needed for England's Crisis

England faces an unprecedented public health challenge as projections indicate a staggering 6.3 million new cancer diagnoses by 2040, effectively doubling the current rate and resulting in a new case every two minutes, driven by an aging population and lifestyle factors such as smoking and obesity.

Smoking Drives Pancreatic Cancer via Immune Suppression
Research & Development Smoking Drives Pancreatic Cancer via Immune Suppression

What if a single puff of cigarette smoke could turn the body's own defenses into a weapon for one of the deadliest cancers? Pancreatic cancer, a disease with a grim five-year survival rate of just 12%, claims over 60,000 new victims annually in the U.S. alone, and for smokers, the danger

Innovative Biocatalytic Method Boosts Drug Discovery
Research & Development Innovative Biocatalytic Method Boosts Drug Discovery

In the ever-evolving landscape of pharmaceutical research, a staggering challenge persists: the need to uncover novel compounds that can tackle complex diseases with precision and efficacy, especially as resistance to existing drugs continues to grow. Scientists have long grappled with the

Can WiFi Devices Revolutionize Health Monitoring at Home?
Tech & Innovation Can WiFi Devices Revolutionize Health Monitoring at Home?

What if the very device connecting your home to the internet could also safeguard your health? Picture a typical morning: coffee brews in the kitchen, a laptop streams the latest news, and silently, the same WiFi router tracks heart rates with precision rivaling medical tools. This isn’t a distant

Once-Weekly Insulin Icodec Cuts Hospitalizations in Trials
Research & Development Once-Weekly Insulin Icodec Cuts Hospitalizations in Trials

In a world where diabetes affects millions and places an immense strain on healthcare systems globally, a revolutionary approach to treatment has emerged from the Phase 3a ONWARDS 1–6 trials, showcasing the potential of Once-Weekly Insulin Icodec. This innovative therapy, distinct from the daily

Can AI Predict Heart Attack Risks Better Than Experts?
Tech & Innovation Can AI Predict Heart Attack Risks Better Than Experts?

What if a machine could save a life by seeing what even the sharpest human eye might miss? In the high-stakes world of heart health, where every second counts after a heart attack, artificial intelligence (AI) is stepping into the spotlight with groundbreaking potential. A recent study has revealed

NVIDIA's CUDA-Q: Revolutionizing Quantum AI in Drug Discovery
Research & Development NVIDIA's CUDA-Q: Revolutionizing Quantum AI in Drug Discovery

Imagine a world where the development of life-saving drugs, a process that often stretches over a decade and costs billions of dollars, is condensed into just a few months with remarkable precision. This isn’t a distant dream but a tangible reality being shaped by NVIDIA through its innovative

Trend Analysis: Mitochondrial Microproteins in Therapy
Research & Development Trend Analysis: Mitochondrial Microproteins in Therapy

Imagine a world where the smallest, most overlooked components of human cells hold the key to combating some of the most pressing health crises, such as obesity and aging. Mitochondrial microproteins, tiny yet powerful regulators within cells, are emerging as a groundbreaking focus in biomedical

How Did QEH Become UK's Fastest in Hip Fracture Research?
Research & Development How Did QEH Become UK's Fastest in Hip Fracture Research?

In a landscape where medical research often progresses at a cautious pace, the Queen Elizabeth Hospital (QEH) has emerged as a trailblazer, setting a remarkable benchmark in the United Kingdom by achieving the extraordinary feat of becoming the fastest site in the UK to recruit 100 participants for

LifeMD's Collapse: Lessons on Telehealth Fraud and Volatility
Tech & Innovation LifeMD's Collapse: Lessons on Telehealth Fraud and Volatility

The telehealth industry has emerged as a transformative force in healthcare, offering unprecedented access to medical services through digital platforms, yet the spectacular downfall of LifeMD, Inc. (NASDALFMD) exposes the sector's vulnerabilities in a way that demands attention. This company, once

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later